Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Policy Alerts

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 29 September 2006:
Vol. 313. no. 5795, p. 1849
DOI: 10.1126/science.313.5795.1849i
Prev | Table of Contents | Next

This Week in Science

In the mouse, the immune system can recognize a developing tumor and control its growth, but whether the same is true in humans has been controversial. To investigate the impact of the immune response on the prognosis of cancer patients, Galon et al. (p. 1960; see the news story by Couzin) analyzed tumor-infiltrating immune cells in human colorectal cancers by gene expression profiling and in situ immunohistochemistry. In three independent patient populations, the properties of the immune cells (type, density, and location) within the tumors were a better predictor of recurrence and overall patient survival than tumor histopathology. Thus, information about the immune response in individual cancer patients could help optimize treatment decisions.




ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)